|525 Market St. , San Francisco, CA 94105|
|Fund Manager||Team Managed|
The Fund seeks long-term total return, consisting of capital appreciation and current income. he Fund invests in equity and fixed income securities with an emphasis on equity securities. Under normal circumstances, we invest at least 80% of the Funds net assets in equity and fixed income securities designed to replicate the holdings and weightings of the securities comprising the S&P 500 Index and Bloomberg Barclays U.S. Treasury Index. We seek to achieve the Funds investment objective by allocating up to 75% of its assets in equity securities and up to55% of its assets in fixed income securities.
|Asset Type||% Of Allocation|
|Total Net Assets||1.06 B|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$250|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 06/30/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 06/30/2021|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|AMZN||AMAZON COM INC||2.44%|
|GOOGL||ALPHABET INC CLASS A||1.21%|
|GOOG||ALPHABET INC CLASS C||1.18%|
|BRK.B||BERKSHIRE HATHAWAY INC CL B||0.87%|
|TSLA||TESLA MOTORS INC||0.87%|
|JPM||JPMORGAN CHASE & CO||0.78%|
Join the Action Alerts PLUS Community today!
SpaceX CEO Elon Musk says the company’s Starlink high-speed internet service will come out of beta testing next month.
Whether the news is good or bad, you can take advantage of it if you understand why you're involved in a stock in the first place.
Just because we're in the market's worst month of the year doesn't mean there aren't good investments available.
Parus files a second patent infringement lawsuit against Apple, alleging it infringed on its patents for voice-browsing and device control technology.
Accounts payable software provider AvidXchange on Friday filed for a initial public offering.
Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.